when separately specified in other Schedules Coca leaf DMT Harmine/Harmaline Heroin Kratom, also known as Mitragyna speciosa; as well its main alkaloid Mitragynine MDPV Mephedrone Mescaline Methaqualone Methoxypiperamide LSD Salvia divinorum Schedule 10: Substances of such danger to health as to warrant prohibition of sale, supply and use Schedule 10 was known as Appendix C until the introduction of the Poisons Standard 2015. It includes substances of such danger to health as to warrant prohibition of sale, supply and use. Examples are: Borage for therapeutic use except the fixed oil derived from the seeds of Borago officinalis. Coal tar for cosmetic use other than in therapeutic goods. Juniperus sabina for therapeutic use Oxyphenisatin for therapeutic use 2,4-Dinitrophenol for human use As of 15 August 2022, Schedule 10 includes each of the following substances: Abrus precatorius (Jequirity) seed or root for therapeutic use. Acorus calamus (calamus) for human therapeutic use. Alkaline Salts, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for domestic use: a) in liquid or semi-solid food additive preparations, the pH of which is more than 11.5; b) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or c) in liquid or semi-solid automatic dishwashing preparations, the pH of which is more than 12.5. Alkylamines WITH STIMULANT PROPERTIES except when separately specified in these schedules. Allylisopropylacetylurea for therapeutic use. 2-AMINO-5-METHYLPHENOL in preparations for cosmetic use. Aminophenazone (amidopyrine) and its derivatives for human therapeutic use. Amygdalin for therapeutic use. Anchusa officinalis for therapeutic use. o-Anisidine (excluding derivatives) in preparations for skin colouration (including tattooing) and dyeing of hair, eyelashes or eyebrows except in preparations containing 0.001 per cent or less of o-anisidine. Aristolochia spp. for therapeutic use. Aristolochic acid for human therapeutic use. Asarum spp. containing aristolochic acid(s) for human therapeutic use. Azadirachta indica (neem) including its extracts and derivatives, in preparations for human internal use except debitterised neem seed oil. Basic Orange 31 (2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride) in preparations for skin colouration and dyeing of eyelashes or eyebrows. 1,2-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing). 1,3-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing). Bithionol for human therapeutic use. Bragantia spp. containing aristolochic acid(s) for human therapeutic use. Buclosamide for therapeutic use. Buniodyl Sodium for therapeutic use. 1,4-Butanediol (excluding its derivatives) in non-polymerised form in